Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries.
Clara Kayei ChowTu Ngoc NguyenSimone MarschnerRafael DiazOmar RahmanAlvaro AvezumScott A LearKoon TeoKaren E YeatesFernando LanasWei LiBo HuPatricio Lopez-JaramilloRajeev GuptaRajesh KumarPrem K MonyAhmad BahonarKhalid YusoffRasha KhatibKhawar KazmiAntonio L DansKatarzyna ZatonskaKhalid F AlhabibIolanthe Marike KrugerAnnika RosengrenSadi GulecAfzalhussein YusufaliJephat ChifambaSumathy RangarajanMartin MckeeSalim Yusufnull nullPublished in: BMJ global health (2021)
Lower availability and affordability of essential CVD medicines were associated with higher risk of MACEs and mortality. Improving access to CVD medicines should be a key part of the strategy to lower CVD globally.